Cardiotrophin‐1 is an anti‐inflammatory cytokine and promotes IL‐4–induced M2 macrophage polarization
暂无分享,去创建一个
J. Prieto | P. Navas | M. Romero-Gómez | S. Hervás-Stubbs | E. Santamaría | M. Bustos | U. Mancheño | M. J. Perugorria | Eduardo Larequi | David Carneros | J. M. Vélez-Ortiz | M. Reboredo | M. Romero‐Gomez | M. Perugorria | J. Prieto
[1] J. T. Afshari,et al. Macrophage plasticity, polarization, and function in health and disease , 2018, Journal of cellular physiology.
[2] L. Rashed,et al. A Novel Role of a Chemotherapeutic Agent in a Rat Model of Endotoxemia: Modulation of the STAT-3 Signaling Pathway , 2018, Inflammation.
[3] E. McNeill,et al. Metabolic Regulation of Adipose Tissue Macrophage Function in Obesity and Diabetes , 2017, Antioxidants & redox signaling.
[4] S. Rose-John. The Soluble Interleukin 6 Receptor: Advanced Therapeutic Options in Inflammation , 2017, Clinical pharmacology and therapeutics.
[5] T. McLaughlin,et al. Role of innate and adaptive immunity in obesity-associated metabolic disease , 2017, The Journal of clinical investigation.
[6] G. Carpino,et al. The Role of Tissue Macrophage-Mediated Inflammation on NAFLD Pathogenesis and Its Clinical Implications , 2017, Mediators of inflammation.
[7] M. Febbraio,et al. The role of gp130 receptor cytokines in the regulation of metabolic homeostasis , 2016, Journal of Experimental Biology.
[8] S. McCormick,et al. Regulation of Macrophage, Dendritic Cell, and Microglial Phenotype and Function by the SOCS Proteins , 2015, Front. Immunol..
[9] H. Hermanns. Oncostatin M and interleukin-31: Cytokines, receptors, signal transduction and physiology. , 2015, Cytokine & growth factor reviews.
[10] F. Schaper,et al. Interleukin-6: Biology, signaling and strategies of blockade. , 2015, Cytokine & growth factor reviews.
[11] M. Moreno-Aliaga,et al. Cardiotrophin-1: A multifaceted cytokine. , 2015, Cytokine & growth factor reviews.
[12] Yoshiyuki Hizukuri,et al. IL-10 enhances the phenotype of M2 macrophages induced by IL-4 and confers the ability to increase eosinophil migration. , 2015, International immunology.
[13] J. Mauer,et al. Versatile functions for IL-6 in metabolism and cancer. , 2015, Trends in immunology.
[14] Hongwei Liang,et al. Molecular Mechanisms That Influence the Macrophage M1–M2 Polarization Balance , 2014, Front. Immunol..
[15] M. Moreno-Aliaga,et al. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation. , 2014, Journal of hepatology.
[16] M. Febbraio,et al. From cytokine to myokine: the emerging role of interleukin‐6 in metabolic regulation , 2014, Immunology and cell biology.
[17] L. Partridge,et al. Interleukin-6 signaling promotes alternative macrophage activation to limit obesity-associated insulin resistance and endotoxemia , 2016 .
[18] S. Gordon,et al. The M1 and M2 paradigm of macrophage activation: time for reassessment , 2014, F1000prime reports.
[19] J. Pascual,et al. Cardiotrophin-1 Administration Protects from Ischemia-Reperfusion Renal Injury and Inflammation , 2013, Transplantation.
[20] P. Ward,et al. Myeloid depletion of SOCS3 enhances LPS‐induced acute lung injury through CCAAT/enhancer binding protein δ pathway , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[21] J. Prieto,et al. Cardiotrophin-1 reduces ischemia/reperfusion injury during liver transplant. , 2013, The Journal of surgical research.
[22] Caroline L. Wilson,et al. Tumor progression locus 2/Cot is required for activation of extracellular regulated kinase in liver injury and toll‐like receptor–induced TIMP‐1 gene transcription in hepatic stellate cells in mice , 2013, Hepatology.
[23] E. Benveniste,et al. SOCS3 Deficiency Promotes M1 Macrophage Polarization and Inflammation , 2012, The Journal of Immunology.
[24] Alberto Mantovani,et al. Macrophage plasticity and polarization: in vivo veritas. , 2012, The Journal of clinical investigation.
[25] M. Moreno-Aliaga,et al. Cardiotrophin-1 is a key regulator of glucose and lipid metabolism. , 2011, Cell metabolism.
[26] C. Libert,et al. Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action. , 2010, Cell metabolism.
[27] S. Gordon,et al. Alternative activation of macrophages: mechanism and functions. , 2010, Immunity.
[28] I. Verma,et al. Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice. , 2009, Cell metabolism.
[29] W. Alexander,et al. SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritis. , 2006, The Journal of clinical investigation.
[30] K. Nakao,et al. SOCS1/JAB likely mediates the protective effect of cardiotrophin-1 against lipopolysaccharide-induced left ventricular dysfunction in vivo. , 2005, Circulation journal : official journal of the Japanese Circulation Society.
[31] J. Prieto,et al. Interplay among cardiotrophin‐1, prostaglandins, and vascular endothelial growth factor in rat liver regeneration , 2005, Hepatology.
[32] B. Ryffel,et al. Endogenous leukemia inhibitory factor attenuates endotoxin response , 2005, Laboratory Investigation.
[33] J. Bae,et al. CD137-Deficient Mice Have Reduced NK/NKT Cell Numbers and Function, Are Resistant to Lipopolysaccharide-Induced Shock Syndromes, and Have Lower IL-4 Responses1 , 2004, The Journal of Immunology.
[34] Peter J. Murray,et al. Shaping Gene Expression in Activated and Resting Primary Macrophages by IL-101 , 2002, The Journal of Immunology.
[35] R. Oppenheim,et al. Cardiotrophin-1, a Muscle-Derived Cytokine, Is Required for the Survival of Subpopulations of Developing Motoneurons , 2001, The Journal of Neuroscience.
[36] R. McIntyre,et al. Cardiotrophin-1 attenuates endotoxin-induced acute lung injury. , 1999, The Journal of surgical research.
[37] M. Jordana,et al. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. , 1998, The Journal of clinical investigation.
[38] S. Rose-John,et al. Oncostatin M stimulates the expression and release of the IL-6 receptor in human hepatoma HepG2 cells. , 1997, Journal of immunology.
[39] P. Ghezzi,et al. Cardiotrophin-1 inhibits tumor necrosis factor production in the heart and serum of lipopolysaccharide-treated mice and in vitro in mouse blood cells. , 1996, The American journal of pathology.
[40] P. Waring,et al. Leukemia inhibitory factor protects against experimental lethal Escherichia coli septic shock in mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[41] K. Chien,et al. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[42] G. Fantuzzi,et al. Defective inflammatory response in interleukin 6-deficient mice , 1994, The Journal of experimental medicine.
[43] Alberto Mantovani,et al. Macrophage activation and polarization. , 2008, Frontiers in bioscience : a journal and virtual library.
[44] J. Gauldie,et al. Murine cardiotrophin-1 stimulates the acute-phase response in rat hepatocytes and H35 hepatoma cells. , 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[45] A. Gaggar,et al. CALL FOR PAPERS Translational Research in Acute Lung Injury and Pulmonary Fibrosis Protective effect of suppressing STAT3 activity in LPS-induced acute lung injury , 2022 .